{"id":"NCT03495102","sponsor":"Eli Lilly and Company","briefTitle":"A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes","officialTitle":"A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-04-05","primaryCompletion":"2019-05-28","completion":"2019-10-10","firstPosted":"2018-04-11","resultsPosted":"2020-06-12","lastUpdate":"2020-06-12"},"enrollment":1842,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Dulaglutide","otherNames":["LY2189265"]}],"arms":[{"label":"Dulaglutide 1.5 mg","type":"ACTIVE_COMPARATOR"},{"label":"Dulaglutide 3 mg","type":"EXPERIMENTAL"},{"label":"Dulaglutide 4.5 mg","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of investigational doses of once weekly dulaglutide when added to metformin in participants with type 2 diabetes with inadequate blood sugar control.","primaryOutcome":{"measure":"Change in Hemoglobin A1c (HbA1c) From Baseline","timeFrame":"Baseline, Week 36","effectByArm":[{"arm":"Dulaglutide 1.5 mg","deltaMin":-1.53,"sd":0.04},{"arm":"Dulaglutide 3 mg","deltaMin":-1.71,"sd":0.04},{"arm":"Dulaglutide 4.5 mg","deltaMin":-1.87,"sd":0.04}],"pValues":[{"comp":"OG000 vs OG001","p":"0.003"},{"comp":"OG000 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":12},"locations":{"siteCount":208,"countries":["United States","Argentina","Austria","Canada","Greece","Hungary","Israel","Italy","Mexico","Poland","Puerto Rico","Romania","Russia","Slovakia","Spain","Taiwan"]},"refs":{"pmids":["36894938","35546790","33397768"],"seeAlso":["https://www.lillytrialguide.com/en-US/studies/adult-type-2-diabetes/GBGL#?postal="]},"adverseEventsSummary":{"seriousAny":{"events":53,"n":612},"commonTop":["Nausea","Diarrhoea","Vomiting","Nasopharyngitis","Dyspepsia"]}}